Replies to post #234284 on Anavex Life Sciences Corp (AVXL)

[frrol]

"As I’ve contended, the statement confirms that this new sigma-1 receptor agonist (Anavex 3-71) has been tested on transgenic mice with Alzheimer’s."

You "contended" something that wasn't in contention:
https://www.anavex.com/anavex-3-71-highly-effective-and-disease-modifying-against-all-major-alzheimers-hallmarks-in-preclinical-disease-model/

Does anyone know the current IP ownership behind 3-71? It has the same origins as 2-73 from what I recall.